• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
    All News #Library

    FDA updates label of 33-year-old cancer drug with dose & warning

    ENDPTS

    Laekna with Lilly to develop muscle preserving obesity drug

    PRESS RELEASE

    Kura Oncology to partner with Kyowa Kirin for blood cancer therapy

    PR NEWSWIRE

    UCB receives FDA approval for BIMZELX For hidradenitis suppurativa

    PRESS RELEASE

    Trump likely to pick Johns Hopkins surgeon, for FDA, sources say

    REUTERS

    Jazz Pharma receive FDA approval for biliary tract cancer treatment

    REUTERS

    Sequana Medical Announces EGM for 20 December 2024

    GLOBENEWSWIRE

    Argenx Advance Efgartigimod SC in Idiopathic Inflammatory Myopathy

    GLOBENEWSWIRE

    Orion and Alligator Bio amend agreement 2 bispecific antibodies

    PRESS RELEASE

    CPHI India reports surge in exhibitor numbers

    INDPHARMAPOST

    Emcure Pharma’s SAKHI Diabetes Program Makes Asia Book of Records

    INDPHARMAPOST

    Innate Pharma Releases Its 2025 Financial Calendar

    BUSINESSWIRE

    Trump picks TV`s Dr. Oz to run Medicare and Medicaid

    REUTERS

    Lupin launches Bumetanide Injection USP in US

    INDPHARMAPOST

    GSK’s itch prospect hits mark in phase 3 liver disease trial

    FIERCE BIOTECH

    Drugmaker receives FDA warning letter after hindered inspection

    FDA

    Merck says Keytruda injection on par with approved IV version in trial

    FIERCE PHARMA

    Pfizer cannot recoup $75 M from SEC insider trading settlement

    REUTERS

    WHO lists mpox vaccine by KM Biologics for emergency use

    REUTERS

    Bayer acquires rights to Cytokinetics` heart drug in Japan

    REUTERS

    Theolytics Doses 1st Patient in Ph I/IIa of THEO-260 in Cancer

    GLOBENEWSWIRE

    CancerVax Lands Top Cancer Expert

    GLOBENEWSWIRE

    Curium Completes Early Enrollment of Phase 3 Prostate Cancer Trial

    GLOBENEWSWIRE

    Augere Medical secures NOK 23M in the “first close” funding round

    GLOBENEWSWIRE

    Teleflex To Present At 36th Piper Sandler Healthcare Conference

    GLOBENEWSWIRE

    Achilles Therapeutics Approved to Transfer to Nasdaq Capital Market

    GLOBENEWSWIRE

    Chemomab`s CM-101 Shows Activity in Primary Sclerosing Cholangitis

    GLOBENEWSWIRE

    Spineart Celebrates 100,000 Ti-Life Cages Sold Worldwide

    GLOBENEWSWIRE

    Tiziana Life Announces ALS Trial Grant from ALS Association

    GLOBENEWSWIRE

    Kellner Group Urges AIM Immunotech Stockholders to Vote for Change

    GLOBENEWSWIRE

    Ocugen Announces Data for OCU410 in Geographic Atrophy Treatment

    GLOBENEWSWIRE

    Panavance Announces Misetionamide Inhibits Oncogenic c-MYC

    GLOBENEWSWIRE

    Calvient Unveils Practice Intelligence to Revolutionize Healthcare

    GLOBENEWSWIRE

    Appili Therapeutics Receives Final Court Order for Aditxt Deal

    GLOBENEWSWIRE

    Alterity Appoints Abby Macnish Niven as Company Secretary

    GLOBENEWSWIRE

    EDAP Present at AAGL on Focal One HIFU vs Surgery for Endometriosis

    GLOBENEWSWIRE

    Novartis ranks first in 2024 Access to Medicine Index

    GLOBENEWSWIRE

    Biolojic Design Joins Johnson & Johnson Innovation - JLABS

    GLOBENEWSWIRE

    Spectral AI Raises $5M to Financial Position for FDA Pathway

    GLOBENEWSWIRE

    Ceribell Appoints Kristie as CPO & Brian Price as SVP Marketing

    GLOBENEWSWIRE

    PharmaTher Updates on FDA NDA for Ketamine

    GLOBENEWSWIRE

    Health Catalyst to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Vaxart Reports Inducement Grants Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    Aspargo Labs Appoints Chief Marketing Officer

    GLOBENEWSWIRE

    SpyGlass Completes Enrollment in Glaucoma Drug Delivery Study

    GLOBENEWSWIRE

    Impact BioMedical Issues Shareholder Letter on Recent Achievements

    GLOBENEWSWIRE

    Akari Therapeutics Regains Full Nasdaq Compliance

    GLOBENEWSWIRE

    Inspire Present At Piper Sandler 36th Healthcare Conference

    GLOBENEWSWIRE

    Tenaya Reports Inducement Grants Under NASDAQ Rule 5635(c)(4)

    GLOBENEWSWIRE

    Commure Deploys Ambient AI Platform at Tenet Physician Resources

    GLOBENEWSWIRE

    Cardiff Oncology Announces Patent for Onvansertib in KRAS mCRC

    GLOBENEWSWIRE

    Oruka To Present At Piper Sandler’s 36th Healthcare Conference

    GLOBENEWSWIRE

    Cidara Therapeutics To Participate In Evercore 7th Annual HealthCONx

    GLOBENEWSWIRE

    AIM ImmunoTech Publishes Breast Cancer Data From Roswell Park

    GLOBENEWSWIRE

    Myriad Genetics Announces Prequel® Screening At 8 Weeks Pregnant

    GLOBENEWSWIRE

    Spur Therapeutics to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    GigaGen Doses 1st Patient in Ph 1 of GIGA-2339 for Hepatitis B

    GLOBENEWSWIRE

    Intra-Cellular To Participate In 3 Upcoming Investor Conferences

    GLOBENEWSWIRE

    Catalyst Pharma to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Preclinical Data Shows Anti-Siglec-15 Treatment Improves Bone

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.